- A professional-grade, rapid lateral flow assay designed to detect and differentiate between COVID-19 (SARS-CoV-2), Influenza A, and Influenza B antigens from a single patient sample
Uses
- Point-of-Care Diagnostics:
- Used in urgent care centers, physician office labs, emergency departments, and pharmacies
- Symptomatic Testing:
- Intended for testing individuals who are suspected of having a respiratory viral infection
- Differential Diagnosis:
- Helps clinicians quickly determine whether a patient has COVID-19, the flu, or neither, allowing for immediate "test and treat" workflows
Features
- Triple Detection:
- Identifies SARS-CoV-2, Influenza A, and Influenza B antigens from one anterior nares (nostril) swab
- Ultra-Fast Results:
- Delivers clear, visual results in as fast as 10 minutes
- CLIA-Waived:
- Approved for decentralized hospital labs and physician office labs
- Simple Workflow:
- Requires only a 1-minute swab incubation and a streamlined processing procedure
- Sample Type:
- Anterior nasal swab
Benefits
- Rapid Treatment Decisions:
- Distinguishing between flu and COVID-19 in 10 minutes allows practitioners to prescribe specific antiviral medications (e.g., Paxlovid or Tamiflu) on the same day
- Improved Operational Efficiency:
- Reduces patient wait times and length of stays at clinics and emergency departments
- Cost-Effective:
- Serves as an affordable, visual combo test that eliminates the need for expensive electronic testing readers
- Less Patient Discomfort:
- Utilizes a non-invasive anterior nasal swab rather than a deep nasopharyngeal swab
